Who Just RaisedSouth San Francisco, CA · Health Care · Form D filed Sep 14, 2026
Moonwalk Biosciences, Inc. raised $60M
Moonwalk Biosciences, Inc. is a biotechnology company based in South San Francisco, California. In a Form D filed with the SEC on September 14, 2026, it reported raising $59,999,998 from 7 investors as part of an offering of up to $70,249,973. The first sale in the offering took place on August 26, 2026.
- 2nd Form D since 2024. Earlier new notices: Jan 2, 2024. All filings on EDGAR
- Still raising. $10.2M of the $70.2M offering was still unsold at filing.
$110M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Jan 2, 2024. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 14, 2026 | $60M | $70.2M | 7 |
| Jan 2, 2024 | $49.6M | $56.8M | 24 |
Lead score
37 out of 100
early raise still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $59,999,998
- Offering size
- $70,249,973
- Investors so far
- 7
- First sale
- August 26, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- South San Francisco, California
- Incorporated
- Delaware, 2022
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $59,999,998 | $70,249,973 | 7 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 14, 2026 · Health Care funding in California · September 2026 funding report
Similar raises
Epicrispr Biotechnologies, Inc.
South San Francisco, CA · filed Aug 26First Form DStill raising
Long Bridge Medical, Inc.
South San Francisco, CA · filed Aug 13
3rd Form D since 2023Still raising
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
Tempest Therapeutics, Inc.
Brisbane, CA · filed Oct 145th Form D since 2013
Renue Life Sciences, Inc.
San Carlos, CA · filed Oct 14First Form DStill raising
iPill Inc.
Rowland Heights, CA · filed Oct 132nd Form D since 2025Still raising
White Eagle Sonic Technologies, Inc.
Santa Clara, CA · filed Oct 135th Form D since 2012Still raising